Institute of Hematology & Blood Diseases Hospital, China

NCT07811986

Phase 2Not yet recruiting202620 people10 Sept 2026clinicaltrials.gov

NCT07643103

Phase 2Not yet recruiting202632 people11 Jun 2026clinicaltrials.gov

NCT07471516

Phase 1/2Recruiting20262 people13 Mar 2026clinicaltrials.gov

NCT07188740

Phase 1Recruiting202632 people23 Sept 2025clinicaltrials.gov

NCT07152041

Phase 3Recruiting2025150 people3 Sept 2025clinicaltrials.gov

NCT07034508

Phase 2Not yet recruiting2025134 people24 Jun 2025clinicaltrials.gov

NCT06992128

Phase 2Recruiting2025129 people28 May 2025clinicaltrials.gov

NCT06882057

Phase 2/3Recruiting20253,000 people18 Mar 2025clinicaltrials.gov

NCT06855810

Phase 2/3Recruiting2025610 people4 Mar 2025clinicaltrials.gov

NCT06776510

Phase 1/2Recruiting202520 people15 Jan 2025clinicaltrials.gov

NCT06764238

Phase 2/3Recruiting20251,800 people8 Jan 2025clinicaltrials.gov

NCT06489808

Phase 2Recruiting202489 people8 Jul 2024clinicaltrials.gov

NCT06387121

Phase 2Recruiting202453 people26 Apr 2024clinicaltrials.gov

NCT05870917

Phase 2Active, not recruiting202320 people23 May 2023clinicaltrials.gov

NCT05660473

Phase 2Recruiting2022100 people21 Dec 2022clinicaltrials.gov

NCT05549973

Phase 1Status unknown202232 people22 Sept 2022clinicaltrials.gov

NCT05495035

Phase 1Recruiting202219 people10 Aug 2022clinicaltrials.gov

NCT04463953

Phase 2Completed202025 people9 Jul 2020clinicaltrials.gov

NCT04440267

Phase 2Recruiting202050 people19 Jun 2020clinicaltrials.gov

NCT04423367

Phase 2Completed202018 people9 Jun 2020clinicaltrials.gov